LALPATHLABBSEDR. LAL PATH LABS LTD.· Healthcare ServicesHighNegative
Announced Thu, 8 Oct, 2026 · 13:11 IST

Income Tax Dept files appeal against favorable order at ITAT

LALPATHLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.5%Reaction day
₹1946.30
prior close
₹1920.50
announcement price
In-mkt
timing
Nifty Smallcap 250market-2.4%-0.1% vs market
Healthcare Service Provider peers, median of 27sector-1.7%-0.7% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Smallcap 250 and 0.7 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.1
10m
-0.1
15m
-0.1
30m
-0.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.5-2.4-0.1-1.7-0.7
Next day
-0.9-1.9+1.0-0.5-0.5
2d
+1.2-0.8+2.0-0.3+1.5
3d
-1.8-0.5-1.3-1.9+0.1
4d
-0.5-0.5+0.0+0.9-1.4
5d
-3.1-1.6-1.5-2.1-1.0
1w
-6.0-2.7-3.3-3.2-2.8
15d
-2.0pendingpending-2.5+0.5
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Smallcap 250Sector · Healthcare Service Provider peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Income Tax Department has filed an appeal before the Income Tax Appellate Tribunal (ITAT), New Delhi against an earlier favorable order given to Dr. Lal Path Labs. The dispute relates to disallowance of ESOP expenses of about Rs 32.66 crore for assessment year 2022-23. The Commissioner of Income Tax (Appeals) had earlier allowed relief to the company. The company states it does not reasonably expect any material impact from the outcome of this appeal.

Likely market impact

Routine tax appeal by the department; company expects no material financial impact. Watch for ITAT outcome.